TB Tevogen Bio Holdings Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Tevogen Bio Holdings Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €29m. The latest transaction was reported on 10 July 2026 (Attribution). Among the most active insiders: Saadi Ryan H.. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 July 2026
All Executives37 Thresholds0 Prospectus0 Other0
Declarations 37 total
◆ Director · Executives · 10 Jul 2026
40,000 shares 0Common Stock SEC:0001123292-26-000996:0
◆ Chief Financial Officer · Executives · 10 Jul 2026
40,000 shares 0Common Stock SEC:0001123292-26-000990:0
◆ Director · Executives · 10 Jul 2026
40,000 shares 0Common Stock SEC:0001123292-26-000992:0
◆ Director · Executives · 10 Jul 2026
40,000 shares 0Common Stock SEC:0001123292-26-000991:0
◆ Director · Executives · 10 Jul 2026
40,000 shares 0Common Stock SEC:0001123292-26-000994:0
◆ Director · Executives · 10 Jul 2026
40,000 shares 0Common Stock SEC:0001123292-26-000993:0
◆ Chief Executive Officer · Executives · 10 Jul 2026
1,220,000 shares 0Common Stock SEC:0001123292-26-000995:0
▼ See Remarks · Executives · 10 Mar 2026
19 shares @ US$7.75 0.0% of flow Common Stock SEC:0001123292-26-000465:0
● Chief Executive Officer · Executives · 18 Dec 2025
50,000 shares 0Common Stock SEC:0001123292-25-000765:0
● Chief Financial Officer · Executives · 11 Dec 2025
300,000 shares 0Common Stock SEC:0001123292-25-000757:0
● Chief Executive Officer · Executives · 11 Dec 2025
460,000 shares 0Common Stock SEC:0001123292-25-000755:0
● Chief Executive Officer · Executives · 15 Aug 2025
20,000 shares 0Common Stock SEC:0001062993-25-014586:0
◆ Chief Executive Officer · Executives · 27 Jun 2025
8,000,000 shares 0Common Stock SEC:0001062993-25-012333:0
◆ Chief Commercial Officer · Executives · 27 Jun 2025
200,000 shares 0Common Stock SEC:0001062993-25-012331:0
◆ See Remarks · Executives · 27 Jun 2025
300,000 shares 0Common Stock SEC:0001062993-25-012329:0
◆ Chief Financial Officer · Executives · 27 Jun 2025
750,000 shares 0Common Stock SEC:0001062993-25-012327:0
▼ Chief Executive Officer · Executives · 9 Jun 2025
1,438,206 shares @ US$1.23 99.9% of flow Common Stock SEC:0001062993-25-011293:0
▼ See Remarks · Executives · 12 Mar 2025
232,968 shares @ US$1.09 12.0% of flow Common Stock SEC:0001062993-25-005533:0
▼ See Remarks · Executives · 7 Mar 2025
71,273 shares @ US$1.14 3.9% of flow Common Stock SEC:0001062993-25-005198:0
▼ See Remarks · Executives · 4 Mar 2025
14,639 shares @ US$1.28 0.9% of flow Common Stock SEC:0001062993-25-004850:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021221:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021220:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021222:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021217:0
◆ Director · Executives · 23 Dec 2024
240,000 shares 0Common Stock SEC:0001062993-24-021214:0
25 of 37 declarations
Load more (12 remaining) 关于 Tevogen Bio Holdings Inc. Tevogen Bio Holdings Inc. 是一家生物技术公司，专注于开发用于治疗病毒性疾病和癌症的 T 细胞疗法。该公司在纳斯达克上市，股票代码为 TEVO。